ALK第三代藥物Lorlatinib：效果與安全性的平衡探討，有效就好？ Third-Generation ALK TKI: Balancing Efficacy and Safety

ALK第三代藥物Lorlatinib在臨床上顯示了非常好的效果，但這個藥物是否能夠同時保證安全性呢？今天我們將探討在臨床上選擇藥物時如何平衡效果與安全性之間的關係。這段影片將深入分析Lorlatinib的療效與副作用，並討論其對患者生活品質的影響。希望通過這些分享，能夠幫助患者和醫療專業人士更好地理解藥物選擇中的關鍵考量，從而做出最合適的治療決策。


The third-generation ALK drug Lorlatinib has shown excellent efficacy in clinical settings, but can this drug be both safe and effective? Today, we will explore how to balance efficacy and safety when selecting medications in clinical practice. This video will delve into the effectiveness and side effects of Lorlatinib, and discuss its impact on patients' quality of life. Through these insights, we aim to help patients and medical professionals better understand the key considerations in drug selection, enabling them to make the most appropriate treatment decisions.